Blog

Categories

Seven Core Pieces of the Puzzle: What To Consider When Selecting an Analytical Lab Central Laboratories Patrice Hugo, Ph.D. Seven Core Pieces of the Puzzle: What To Consider When Selecting an Analytical Lab
In the June issue of Contract Pharma, Q2 Solution's Chief Scientific Officer Patrice Hugo discusses the breadth of new tech-enabled analytical laboratory techniques that are making an impact in...
 What are the key ingredients for a best practice R&D approach for tackling infectious disease? Infectious Diseases Patrice Hugo, Ph.D. What are the key ingredients for a best practice R&D approach for tackling infectious disease?
With a renewed interest in vaccine research and development (R&D), stakeholders across the industry are rethinking their approach to the field. Biopharmaceutical companies have growing numbers of...
 Balancing R&D for Disease X and common illnesses Infectious Diseases Vaccines Patrice Hugo, Ph.D. Balancing R&D for Disease X and common illnesses
Stakeholders from across the industry, including biopharmaceutical companies, governments, and non-profit organizations, are rethinking their pandemic readiness in light of the COVID-19 pandemic,...
 Immuno-Oncology Interview - Patrice Hugo Central Laboratories Biomarkers Patrice Hugo, Ph.D. Immuno-Oncology Interview - Patrice Hugo
Our CSO Patrice Hugo recently sat with members of The Conference Forum at the Immuno-Oncology 360° 2019 conference, where he discussed immuno-oncology (IO) lab services. He shared the company's...
 Fighting cancer takes precision Genomics Precision Medicine Patrice Hugo, Ph.D. Fighting cancer takes precision
On February 4, we commemorated World Cancer Day, a day when researchers, physicians, patients and other interested groups acknowledge all the hard work being done to fight this global disease. This...